Literature DB >> 22938476

Expression and clinical significance of STAT3, P-STAT3, and VEGF-C in small cell lung cancer.

Xue Zhao1, Xian Sun, Xiao-li Li.   

Abstract

OBJECTIVE: To determine STAT3, P-STAT3, and VEGF-C expression levels in small cell lung cancers (SCLCs), and discuss their role and clinical significance in SCLC development.
METHOD: Immunohistochemical methods were applied to 128 cases of SCLC and 40 cases of adjacent normal tissue.
RESULTS: The expression levels of STAT3, P-STAT3, and VEGF-C were higher in SCLC than in normal tissue (P<0.05). Pairwise comparisons showed positive correlations with lymph node metastasis, clinical stage, and tumor size (P<0.05). The expression levels were also related with the overall survival rates.
CONCLUSION: STAT3 and VEGF-C play important roles in the development of SCLC, and might be expected to become new targets for SCLC treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938476     DOI: 10.7314/apjcp.2012.13.6.2873

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  27 in total

1.  STAT3 regulation the expression of VEGF-D in HGC-27 gastric cancer cell.

Authors:  Jingyu Deng; Jingli Cui; Nan Jiang; Rupeng Zhang; Li Zhang; Xishan Hao; Han Liang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

2.  Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.

Authors:  Changhe Zhang; Hong Xu; Zhenping Zhou; Ye Tian; Xiaofei Cao; Guochang Cheng; Qinghong Liu
Journal:  Exp Ther Med       Date:  2018-04-05       Impact factor: 2.447

3.  STAT3 is associated with lymph node metastasis in gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Dan Sun; Yi Pan; Yong Liu; Li Zhang; Xishan Hao
Journal:  Tumour Biol       Date:  2013-07-04

4.  Active Stat3 and Her-2 as combined survival predictors show superiority to TNM staging system for postoperative patients with gastric cancer.

Authors:  Ke Sun; Meng Qing Xu; Hai Jun Zhang; Dan Dan Zhang; Wen Yue; Miao Miao Ma; Lin Tao; Wen Jie Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

5.  STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer.

Authors:  Yujuan Chen; Jing Wang; Xiaodong Wang; Xuejuan Liu; Hongjiang Li; Qing Lv; Jingqiang Zhu; Bing Wei; Ying Tang
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

6.  Serum neuron-specific enolase levels were associated with the prognosis of small cell lung cancer: a meta-analysis.

Authors:  Wei-Xin Zhao; Jian-feng Luo
Journal:  Tumour Biol       Date:  2013-06-18

7.  LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway.

Authors:  Su-Zhen Zhou; Han Li; Zhi-Wan Wang; Ming-Hang Wang; Ning Li; Yan-Fang Wang
Journal:  Cell Cycle       Date:  2020-10-16       Impact factor: 4.534

8.  How to target small cell lung cancer.

Authors:  Gerhard Hamilton; Barbara Rath; Ernst Ulsperger
Journal:  Oncoscience       Date:  2015-08-21

9.  Lung Adenocarcinomas and Lung Cancer Cell Lines Show Association of MMP-1 Expression With STAT3 Activation.

Authors:  Alexander Schütz; Katrin Röser; Jana Klitzsch; Franziska Lieder; Fritz Aberger; Wolfgang Gruber; Kristina M Mueller; Alexander Pupyshev; Richard Moriggl; Karlheinz Friedrich
Journal:  Transl Oncol       Date:  2015-04       Impact factor: 4.243

10.  Evaluation of VEGF-C and tumor markers in bronchoalveolar lavage fluid for lung cancer diagnosis.

Authors:  Chao Cao; Zhong-Bo Chen; Shi-Fang Sun; Yi-Ming Yu; Qun-Li Ding; Zai-Chun Deng
Journal:  Sci Rep       Date:  2013-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.